Literature DB >> 8036016

Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.

S Thakur1, H C Lin, W T Tseng, S Kumar, R Bravo, F Foss, C Gélinas, A B Rabson.   

Abstract

The NF-kappa b/Rel and I kappa B proteins are important regulators of lymphocyte activation and gene expression. We have identified a rearrangement of the NFKB-2 gene in the HUT 78 human cutaneous T-cell leukemia (CTCL) line, cDNA and genomic DNA sequence predicted the presence of a truncated 80 kD NFKB-2 precursor protein (p80HT), instead of the normal p100 protein. No wild-type allele was identified. Elevated levels of two aberrantly sized RNAs were detected, and high levels of p80HT and processed p52 protein were present in HUT 78 cell nuclei. The p52 protein bound to a palindromic kappa B DNA motif, however p80HT did not. Rearrangement of the NFKB-2 gene was also detected in DNA from two patients with CTCL. Rearrangement and overexpression of the NFKB-2 gene may contribute to the genesis of a subset of T-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036016

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Authors:  Katie Schumm; Sonia Rocha; Jorge Caamano; Neil D Perkins
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

2.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

Review 3.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

4.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

5.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

6.  Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.

Authors:  C C Chang; J Zhang; L Lombardi; A Neri; R Dalla-Favera
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

7.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

8.  Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.

Authors:  Zhe Wang; Baochun Zhang; Liqun Yang; Jane Ding; Han-Fei Ding
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

9.  Regulation of BRCA1 transcription by specific single-stranded DNA binding factors.

Authors:  Sanjay Thakur; Tatsuya Nakamura; George Calin; Andrea Russo; Joseph F Tamburrino; Masayoshi Shimizu; Gustavo Baldassarre; Sabrina Battista; Alfredo Fusco; Richard P Wassell; Garret Dubois; Hansjuerg Alder; Carlo M Croce
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  A cell cycle regulatory network controlling NF-kappaB subunit activity and function.

Authors:  Benjamin Barré; Neil D Perkins
Journal:  EMBO J       Date:  2007-10-25       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.